1. Home
  2. ABEV vs A Comparison

ABEV vs A Comparison

Compare ABEV & A Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ambev S.A.

ABEV

Ambev S.A.

HOLD

Current Price

$3.07

Market Cap

47.1B

ML Signal

HOLD

Logo Agilent Technologies Inc.

A

Agilent Technologies Inc.

HOLD

Current Price

$140.36

Market Cap

38.0B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
ABEV
A
Founded
1885
1999
Country
Brazil
United States
Employees
N/A
N/A
Industry
Beverages (Production/Distribution)
Biotechnology: Laboratory Analytical Instruments
Sector
Consumer Staples
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
47.1B
38.0B
IPO Year
2012
1999

Fundamental Metrics

Financial Performance
Metric
ABEV
A
Price
$3.07
$140.36
Analyst Decision
Sell
Strong Buy
Analyst Count
4
15
Target Price
$2.94
$161.47
AVG Volume (30 Days)
25.1M
1.8M
Earning Date
05-05-2026
05-27-2026
Dividend Yield
4.93%
0.92%
EPS Growth
N/A
3.16
EPS
N/A
2.27
Revenue
N/A
$4,472,000,000.00
Revenue This Year
$7.96
$8.45
Revenue Next Year
$5.35
$6.13
P/E Ratio
$16.99
$61.33
Revenue Growth
N/A
6.43
52 Week Low
$2.10
$108.35
52 Week High
$3.45
$160.27

Technical Indicators

Market Signals
Indicator
ABEV
A
Relative Strength Index (RSI) N/A 59.02
Support Level N/A $135.75
Resistance Level N/A $139.38
Average True Range (ATR) 0.00 3.76
MACD 0.00 0.06
Stochastic Oscillator 0.00 81.63

Price Performance

Historical Comparison
ABEV
A

About ABEV Ambev S.A.

Ambev is the largest brewer in Latin America and the Caribbean and is Anheuser-Busch InBev's subsidiary in the region. It produces, distributes, and sells beer and PepsiCo products in Brazil and other Latin American countries and owns Argentina's largest brewer, Quinsa. Ambev was formed in 1999 through the merger of Brazil's two largest beverage companies, Brahma and Antarctica. In 2004, Ambev combined with Canadian brewer Labatt, giving AB InBev a controlling interest of 62%.

About A Agilent Technologies Inc.

Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and diagnostics, cross lab operations consisting of consumables and services, and applied end markets. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.

Share on Social Networks: